EUVIMEDEUVIMED entdecken
Crossref

Stabilization Strategies, Excipient Optimization, and Bioavailability Enhancement in Monoclonal Antibody-Based Biopharmaceutical Formulations

ATTHAPU THIRUPATHAIAH

International Journal of Drug Delivery Technology · 05.06.2026 · 16 (49s)

DOI: 10.25258/ijddt.16.49s.17 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 05.06.2026. Verfasst von ATTHAPU THIRUPATHAIAH.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The monoclonal antibodies (mAbs) are vulnerable to physicochemical instability in terms of aggregate formation, thermal denaturation, and high viscosity, which considerably affect their clinical application. This paper aims at overcoming the stated problems via the systematic optimization of excipient systems based on the findings obtained experimentally as well as structural analysis of the data available in the Protein Data Bank. The excipients under consideration include sucrose, trehalose, arginine, histidine, and polysorbate 80, all used widely in clinical practice. The results of optimization showed significant enhancements in terms of essential stability characteristics. Protein aggregation was decreased by 57%, with the corresponding value of the ratio falling from 0.42 to 0.18. Thermal stability was also enhanced by increasing the value of melting temperature from 62 °C to 78 °C. In addition, solubility was improved from 45 mg/mL to 92 mg/mL; at the same time, the viscosity parameter dropped from 3.5 cP to 2.1 cP, indicating a possibility to obtain a more viable formulation of high concentrations. The molecular interaction energy evaluation confirmed a positive effect of the developed approach by identifying a more favorable binding energy of −185 kJ/mol compared to −120 kJ/mol in control systems. Of particular interest is the fact that the combination of multiple excipients, such as sucrose, arginine, and polysorbate 80, proved to be highly resistant to thermal stress and freezing and thawing operations, thus, showing no signs of protein aggregation or structural damage. The obtained results confirm the significance of protein–excipient interaction optimization and synergic effects between various types of additives as one of the most effective approaches in achieving stable formulations.

Zitieren

APA

THIRUPATHAIAH, A. (2026). Stabilization Strategies, Excipient Optimization, and Bioavailability Enhancement in Monoclonal Antibody-Based Biopharmaceutical Formulations. International Journal of Drug Delivery Technology, 16(49s). https://doi.org/10.25258/ijddt.16.49s.17

Vancouver

THIRUPATHAIAH A. Stabilization Strategies, Excipient Optimization, and Bioavailability Enhancement in Monoclonal Antibody-Based Biopharmaceutical Formulations. International Journal of Drug Delivery Technology. 2026;16(49s). doi:10.25258/ijddt.16.49s.17

BibTeX
@article{THIRUPATHAIAH2026,
  author = {THIRUPATHAIAH, ATTHAPU},
  title = {Stabilization Strategies, Excipient Optimization, and Bioavailability Enhancement in Monoclonal Antibody-Based Biopharmaceutical Formulations},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {49s},
  doi = {10.25258/ijddt.16.49s.17}
}
Kostenlos starten →